METASTATIC MALIGNANT TESTICULAR NON-SEMINOMATOUS GERM CELL TUMOR

Clinical trials for METASTATIC MALIGNANT TESTICULAR NON-SEMINOMATOUS GERM CELL TUMOR explained in plain language.

Never miss a new study

Get alerted when new METASTATIC MALIGNANT TESTICULAR NON-SEMINOMATOUS GERM CELL TUMOR trials appear

Sign up with your email to follow new studies for METASTATIC MALIGNANT TESTICULAR NON-SEMINOMATOUS GERM CELL TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New hope to save hearing for cancer patients

Symptom relief Recruiting now

This early-stage trial is testing whether adding a drug called Pedmark to standard chemotherapy can reduce hearing damage in men with metastatic testicular cancer. The study will compare hearing outcomes between two groups: one receiving chemotherapy alone and one receiving chemo…

Matched conditions: METASTATIC MALIGNANT TESTICULAR NON-SEMINOMATOUS GERM CELL TUMOR

Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Symptom relief

Last updated Mar 24, 2026 12:03 UTC

METASTATIC MALIGNANT TESTICULAR NON-SEMINOMATOUS GERM CELL TUMOR

Get alerted when new METASTATIC MALIGNANT TESTICULAR NON-SEMINOMATOUS GERM CELL TUMOR trials appear

New hope to save hearing for cancer patients